Éric François

Pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer: Phase 3 KEYNOTE-181 study.

Manish A. Shah, Antoine Adenis, Peter C. Enzinger et al. · Journal of Clinical Oncology · 2019 · 52 citations

Medicine, Oncology, Pharmacotherapy +17

Controlled transperitoneal percutaneous cecostomy as a therapeutic alternative to the endoscopic decompression for Ogilvie's syndrome

P. Chevallier, Pierre-Yves Marcy, Éric François et al. · The American Journal of Gastroenterology · 2002 · 49 citations

Medicine, Surgery, Bowel Management +15

Cisplatin Nephrotoxicity: A Multivariate Analysis of Potential Predisposing Factors

J. L. Lagrange, Blandine Médecin, Marie Christine Etienne et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 1997 · 25 citations

Pharmacy, Oncology, Pharmacology +17

Atezolizumab plus modified DCF (docetaxel, cisplatin, and 5-fluorouracil) as first-line treatment for metastatic or locally advanced squamous cell anal carcinoma: A SCARCE-PRODIGE 60 randomized phase II study.

Stéfano Kim, François Ghiringhelli, Christelle de la Fouchardière et al. · Journal of Clinical Oncology · 2022 · 17 citations

Medicine, Oncology, Pharmacology +17

Performance comparison of two PCM candidates for new concept of compact thermal storage in solar DHW systems

Gilles Fraisse, Maxime Thonon, Laurent Zalewski et al. · Journal of Energy Storage · 2024 · 12 citations · Full text

Engineering, Materials Engineering, Materials Science +17